x
Breaking News
0

Celgene Corporation (CELG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Celgene's earnings

Delivery Method

Status

Add to/Remove from a Portfolio My Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
133.85 -0.46    -0.34%
26/06 - Closed. Currency in USD ( Disclaimer )
After Hours
133.50
-0.35
-0.26%
26/06
Type: Equity
Market: United States
ISIN: US1510201049 
CUSIP: 151020104
  • Volume: 3,883,232
  • Bid/Ask: 133.50 / 134.20
  • Day's Range: 132.56 - 134.44
Start Trading
Celgene 133.85 -0.46 -0.34%

CELG Overview

 
Information about the Celgene Corporation Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close134.31
Day's Range132.56 - 134.44
Revenue11.68B
Open134.23
52 wk Range96.06 - 135.18
EPS2.65
Volume3,883,232
Market Cap104.87B
Dividend (Yield)0 (N/A)
Average Vol. (3m)3,814,050
P/E Ratio50.59
Beta1.92
1-Year Change39.01%
Shares Outstanding780,824,335
Next Earnings DateN/A

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Buy Buy Buy Buy Buy
Technical Indicators BUY Strong Buy Strong Buy Strong Buy Strong Buy
Summary Buy Strong Buy Strong Buy Strong Buy Strong Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Inverted Hammer 30 Current
Harami Bearish 1W Current
Bullish Engulfing 1M Current
Completed Patterns
Evening Doji Star 1M 2 Apr 17
Upside Gap Two Crows 1M 2 Apr 17
Doji Star Bearish 1M 3 Mar 17

Celgene Corporation News & Analysis

News


Celgene Corporation Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 133.85 133.50 134.20 3,883,232 -0.34% USD 26/06  
  Mexico 2,400.00 0.00 0.00 3,778 -0.36% MXN 26/06  
  Switzerland 133.00 0.00 0.00 170 +2.70% USD 26/06  
  Switzerland 129.50 115.00 139.90 235 +2.45% CHF 26/06  
  Xetra 119.15 118.60 118.85 1,984 +0.04% EUR 26/06  
  Berlin 119.68 119.36 119.84 0 +0.47% EUR 26/06  
  Frankfurt 119.86 119.48 119.73 281 +0.53% EUR 26/06  
  Stuttgart 120.15 0.00 0.00 195 +1.03% EUR 26/06  
  TradeGate 119.90 119.31 120.04 1,920 +0.07% EUR 26/06  
  Munich 119.71 0.00 0.00 0 +0.19% EUR 26/06  
  Vienna 118.630 0.000 0.000 0 -0.27% EUR 26/06  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  SBI 281.05 289.45 279.30 -7.90 -2.73% 8.70M 05:15:00  
  Aurobindo Pharma 678.25 692.65 675.60 +6.00 +0.89% 2.68M 05:15:00  
  Jaiprakash Associates 20.30 22.50 19.80 +1.55 +8.27% 105.77M 05:14:00  
  Reliance Capital 656.80 658.95 640.80 +5.30 +0.81% 1.84M 05:14:00  
  AXIS Bank 491.90 506.70 490.60 -12.75 -2.53% 2.06M 05:15:00  
  Zee Entertainment 493.65 511.50 492.10 -16.10 -3.16% 632.95K 05:15:00  
  Indiabulls RE 206.650 208.450 201.200 +2.200 +1.08% 9.56M 05:15:00  
  Oil & Natural Gas 156.10 158.95 155.20 -2.00 -1.27% 1.58M 05:15:00  
  Apple 145.82 148.28 145.38 -0.46 -0.31% 25.69M 26/06  
  Sun Pharma 543.55 549.40 541.00 -0.25 -0.05% 1.23M 05:14:00  

Celgene Corporation Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

7132

Equity Type

ORD

Celgene Corporation is an integrated global biopharmaceutical company. The Company, together with its subsidiaries, is engaged in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases through solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. Its commercial-stage products include REVLIMID (lenalidomide), POMALYST/IMNOVID (pomalidomide), OTEZLA (apremilast), ABRAXANE (paclitaxel albumin-bound particles for injectable suspension), VIDAZA, azacitidine for injection (generic version of VIDAZA) and THALOMID (thalidomide). Its clinical trial activity includes trials across the disease areas of hematology, solid tumors, and inflammation and immunology. The Company also markets ISTODAX, which is an epigenetic modifier. The Company is also evaluating AG-221 (enasidenib) in combination with VIDAZA in newly diagnosed acute myeloid leukemia with isocitrate dehydrogenase-2 mutations.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
Securities and Exchange Commission (United States) Start Trading
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading

My Sentiments

Add your sentiment:
or
 
Members' Sentiments:
Bullish
100%
Bearish
0%

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post
Post also to:
1000
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Please wait a minute before you try to comment again.
 
 
 
Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Add Chart to Comment
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.